secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2026-07-10T01:03:42+00:00
Accession:  0001140361-26-028154
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis reaffirms FY 2026 financial guidance unchanged from April 29 release
--------------------------------------------------------------------------

- Reaffirmed FY 2026 financial guidance on July 9, 2026.
- Guidance unchanged from that provided on April 29, 2026 in Q1 earnings release.
- No specific financial figures disclosed in this filing; refer to prior release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036126028154/0001140361-26-028154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036126028154/ef20077783_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-028154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer